23 May 2013
Keywords: Germany, Multiple sclerosis, Research progress
Article | 30 May 2011
Multiple sclerosis (MS) sufferers should soon have access to a range of drugs that offer better protection against relapses and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 May 2011
31 May 2011
22 May 2013
© 2013 thepharmaletter.com